Glial-derived neurotrophic factor promotes aberrant basal cell hyperplasia in nasal polyps
Clinical Immunology · 2025
DOI: 10.1016/j.clim.2025.110604 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Immunology, 2025. Verfasst von Yilin Hou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Otorhinolaryngology, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Cente…. Hauptthemen laut MEDLINE: Nasal Polyps, Glial Cell Line-Derived Neurotrophic Factor, Rhinosinusitis. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guangzhou Science and Technology Program Key Projects, Guangdong Provincial Natural Science Foundation, Shenzhen Science and Technology Innovation Committee.
Abstract (Originalsprache)
BACKGROUND: Neurotrophins are elevated in nasal polyps (NPs) and/or allergies, exerting neurogenic inflammatory effects. Non-classical glial-derived neurotrophic factor (GDNF) family ligands (GFLs) remain poorly understood in chronic rhinosinusitis with NP (CRSwNP). METHODS: GDNF expression was analyzed in 67 nasal fluids (NFs) and 44 tissues via proteomic, transcriptomic, and immunohistochemical assays. Immunofluorescence co-staining identified GDNF and p63 + basal cells (BCs). Functional studies in human nasal epithelial cells (HNECs) assessed GDNF's affects on proliferation and barrier integrity. Bioinformatics identified regulatory networks and drug candidates. RESULTS: GDNF existed in NFs and tissues of CRSwNP, with higher abundance in eosinophilic NPs. P63 + BCs expression positively correlates with GDNF levels. GDNF potently activated MAPK/PI3K/Akt signaling in HNECs and induced Ki-67+/p63 + cells proliferation, while reduced distribution of claudin-1 at junctions. miR-204-5p/211-5p and two FDA-approved neuroactive drugs were predicted as GDNF modulators. CONCLUSIONS: GDNF drives aberrant epithelial remodeling in CRSwNP via MAPK/PI3K signaling, highlighting its therapeutic potential for refractory disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Otorhinolaryngology, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Guangdong province, China; Department of Otorhinolaryngology, First…
- Department of Otorhinolaryngology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, PR China; Department of Allergy, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P…
- Department of Cardiology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
- Otorhinolaryngology, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Guangdong province, China.
- Otorhinolaryngology, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Guangdong province, China. Electronic address: hyihu@sina.com.
Förderung
- Guangzhou Science and Technology Program Key Projects
- Guangdong Provincial Natural Science Foundation
- Shenzhen Science and Technology Innovation Committee
Zitieren
APA
Hou, Y., Sun, L., Su, M., Yang, W., Ji, L., Zhou, Y., Lu, X., Yin, N., Zhao, J., Qiu, Z., Wei, Y., Wen, W., & Hu, H. (2025). Glial-derived neurotrophic factor promotes aberrant basal cell hyperplasia in nasal polyps. Clinical Immunology. https://doi.org/10.1016/j.clim.2025.110604
Vancouver
Hou Y, Sun L, Su M, Yang W, Ji L, Zhou Y, et al. Glial-derived neurotrophic factor promotes aberrant basal cell hyperplasia in nasal polyps. Clinical Immunology. 2025. doi:10.1016/j.clim.2025.110604
BibTeX
@article{Hou2025,
author = {Hou, Yilin and Sun, Lin and Su, Mengqi and Yang, Weiqiang and Ji, Lingchao and Zhou, Yaqi and Lu, Xiaochan and Yin, Na and Zhao, Jiaqi and Qiu, Zihan and Wei, Yi and Wen, Weiping and Hu, HongYi},
title = {Glial-derived neurotrophic factor promotes aberrant basal cell hyperplasia in nasal polyps},
journal = {Clinical Immunology},
year = {2025},
doi = {10.1016/j.clim.2025.110604}
}
EUVIMED